Luye Pharma Group (2186) Ownership - Who Owns Luye Pharma Group?

Q: What percentage of Luye Pharma Group Ltd. (HK:2186) stock is held by retail investors?

According to the latest TipRanks data, approximately 63.76% of Luye Pharma Group Ltd. (HK:2186) stock is held by retail investors.

Q: Who owns the most shares of Luye Pharma Group Ltd. (HK:2186)?

Dian Bo Liu owns the most shares of Luye Pharma Group Ltd. (HK:2186).

Q: What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

3 Followers

Luye Pharma Group (2186) Ownership Overview

31.20%

Insiders

2.36%

Mutual Funds

2.69% ETFs

63.76% Public Companies and

Individual Investors

The ownership structure of Luye Pharma Group (HK:2186) stock is a mix of institutional, retail, and individual investors. , 31.20% is owned by Insiders, and 63.76% is owned by Public Companies and Individual Investors.

The ownership structure of Luye Pharma Group (HK:2186) stock is a mix of institutional, retail, and individual investors. Approximately 5.05% of the company’s stock is owned by Institutional Investors, 31.20% is owned by Insiders, and 63.76% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
1,246,108,703	Insider	31.20%	451,091,350
44,980,500	Institution	1.13%	16,282,941
36,832,731	Institution	0.92%	13,333,449
33,941,917	Institution	0.85%	12,286,974
29,697,539	Institution	0.74%	10,750,509
28,197,000	Institution	0.71%	10,207,314
15,033,500	Institution	0.38%	5,442,127
3,600,221	Institution	0.09%	1,303,280
2,315,728	Institution	0.06%	838,294
1,349,000	Institution	0.03%	488,338

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
33,941,917	Institution	0.85%	12,286,974
29,697,539	Institution	0.74%	10,750,509
28,197,000	Institution	0.71%	10,207,314
1,110,369	Institution	0.03%	401,954
526,500	Institution	0.01%	190,593
416,000	Institution	0.01%	150,592
249,500	Institution	<0.01%	90,319
189,500	Institution	<0.01%	68,599
1	Institution	0.00%	0

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard FTSE Emerging Markets ETF	28,180,956	Institution	0.71%	9,320,662
iShares Core MSCI Emerging Markets ETF	24,889,000	Institution	0.62%	9,060,645
Avantis Emerging Markets Equity ETF	14,734,000	Institution	0.37%	5,390,374
Vanguard FTSE All-World ex-US Index Fund	4,433,461	Institution	0.11%	1,466,337
iShares Core MSCI Total International Stock ETF	3,030,500	Institution	0.08%	1,103,230
Schwab Emerging Markets Equity ETF	2,315,728	Institution	0.06%	848,696
SPDR Portfolio Emerging Markets ETF	1,597,500	Institution	0.04%	585,471
SPDR S&P Emerging Markets Small Cap ETF	1,511,221	Institution	0.04%	553,851
iShares MSCI EM IMI ESG Screened UCITS ETF	1,169,000	Institution	0.03%	428,429
Dimensional Emerging Markets Value ETF	1,057,000	Institution	0.03%	387,382

FAQ

Who Owns Luye Pharma Group Ltd. (HK:2186)?

Currently, no data Available

What percentage of Luye Pharma Group Ltd. (HK:2186) stock is held by institutional investors?

Currently, no data Available

What percentage of Luye Pharma Group Ltd. (HK:2186) stock is held by retail investors?

According to the latest TipRanks data, approximately 63.76% of Luye Pharma Group Ltd. (HK:2186) stock is held by retail investors.

Who owns the most shares of Luye Pharma Group Ltd. (HK:2186)?

Dian Bo Liu owns the most shares of Luye Pharma Group Ltd. (HK:2186).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.